MedTrace Logo

Characterization of the Gastrointestinal Microbiota in Term Newborn Infants After 4 Weeks Supplementation of Probiotics

NCT04994834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2022-07-12

No results posted yet for this study

Summary

A mono center, open label, pilot study in term newborn infants. The study will investigate the effect of supplementation with probiotics on the presence of total Bifidobacterium in the infant feces.

Conditions

  • Gut Microbiota

Interventions

DIETARY_SUPPLEMENT

Probiotics

Once a day daily intake of probiotics for at least 28 consecutive starting within 24 hours after birth

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Chr Hansen

    lead INDUSTRY

Principal Investigators

  • Lars Henning Pedersen, Professor · Department of Gynecology and Obstetrics, Aarhus University Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Days
Max Age
2 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2022-03-30
Completion
2022-06-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04994834 on ClinicalTrials.gov